 Marseille, Jan. 04, 2021 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH ISIN: FR0010331421; Nasdaq: IPHA Innate or the Company announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences. 